|
|
|
|
Learn new strategies, explore a compelling case study, and gain actionable insights for your mRNA work, in this session packed with scientific value. Christian Cobaugh, Founder and Chief Scientific Officer, presents this webinar discussing key quality attributes of mRNA and LNPs essential for improving drug efficacy and safety.
|
|
|
|
|
Explore this detailed scientific poster, Methods for mRNA poly(A) Sizing Using RNase Digestion, Capillary Gel Electrophoresis, and Nanopore-based Sequencing. It showcases the innovative application of Vernal’s mRNA and LNP Analytical Services, highlighting advanced methodologies for precise mRNA analysis and characterization.
|
|
|
|
|
|
|
In collaboration, Charles River Lab and Vernal Biosciences released this scientific poster. Since its release, new advancements have been made, and new data is available to share. Join us December 12 to dive into the data and hear from the researchers directly. Register Now.
|
|
|
|
MAXIMIZE YOUR REMAINING 2024 BUDGET
|
|
|
|
|
The clock’s ticking — and so is your chance to make every dollar count. Maximize your budget with up to 25% off Vernal's premium mRNA catalog and get a pair of free branded socks with each purchase.
Start Saving.
|
|
|
|
|
|
Confidently Measure CQAs For Drug Development
|
Whether you’re advancing vaccines, gene therapies, or innovative formulations, we will generate the insights you need for a deeper understanding and informed decision-making, enhancing risk management and preventing costly delays in your development timeline.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
Scalability And Purity For Preclinical Studies
|
Designed to help advance lead candidates through preclinical development where larger quantities of high-quality material are required, our high-purity mRNA production and advanced LNP formulations ensure rapid and seamless scaling, effective mRNA delivery, and reliable results.
|
|
• Request Information
|
|
|
|
|
|
|
|
